Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Non-contrast Enhanced Cardiac Magnetic Resonance Imaging in the Diagnosis and Classification of Pulmonary Hypertension (CMR-PH)

This study is enrolling participants by invitation only.
Information provided by (Responsible Party):
Ursula Reiter, Medical University of Graz Identifier:
First received: November 3, 2012
Last updated: April 27, 2016
Last verified: April 2016